Ashwani Bassi is a Cardiology physician affiliated with Sinai Hospital. OpenAlex indexes 7 publications with 1,171 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
325 Hospital Dr
Suite 108
Glen Burnie, MD 210615860
Telephone
410-863-8860Registry record last updated 8 Jul 2007.
Industry payments
49 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202512 payments
- Lundbeck LLCProgram year20255 payments
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.2%Beta blocker19.3%Metoprolol Tartrate43%Metoprolol Succinate40%Carvedilol17%Part D≥43 patientsStatin7.6%Atorvastatin Calcium68%Rosuvastatin Calcium32%Part D≥27 patients+ 12 more classes in this area
Blood & clotting
41.8%Platelet Aggregation Inhibitor23.7%Dipyridamole100%Part B, office-administered≥71 patientsFactor Xa inhibitor14.7%Eliquis76%Xarelto24%Part D≥52 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bivalirudin and Clopidogrel With and Without Eptifibatide for Elective Stenting: Effects on Platelet Function, Thrombelastographic Indexes, and Their Relation to Periprocedural Infarction
Journal of the American College of Cardiology
2009 - Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting
Blood Coagulation & Fibrinolysis
2008 - Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology
2007 - Platelet Reactivity in Patients and Recurrent Events Post-Stenting
Journal of the American College of Cardiology
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Henry Fein, MD
Sinai Hospital
Debra Counts, MD
Sinai Hospital
Ira Garonzik, MD
Sinai Hospital
Donald Abrams, MD
Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”